What's Happening?
Amplitude Vascular Systems (AVS), a medical device company focused on treating calcified arterial disease, has opened a new global headquarters in Waltham, Massachusetts. The 37,811 square-foot facility will serve as a hub for innovation, operations, and commercialization. This expansion supports the company's growth and the development of its novel device for pulsatile intravascular lithotripsy (PIVL). The new headquarters is equipped with state-of-the-art technology and includes space for research and development, manufacturing, and general use.
Why It's Important?
The opening of AVS's new headquarters marks a significant milestone in the company's expansion and its efforts to bring innovative medical solutions to market. The facility's location in the Greater Boston area, a hub for life sciences innovation, provides access to top talent and resources. This expansion is expected to accelerate the development and commercialization of AVS's PIVL system, which aims to improve the treatment of calcified arterial disease. The company's growth also promises to create quality job opportunities in the region.
What's Next?
AVS plans to continue its momentum towards regulatory approval in the U.S. and aims to bring its intravascular lithotripsy therapy to market. The company is preparing for the commercialization of its first platform in mid-2026, with ongoing studies and trials to support its regulatory submissions. The new headquarters will play a crucial role in supporting these efforts and facilitating further innovation in the treatment of arterial disease.
